138 related articles for article (PubMed ID: 11979403)
1. C3, hormone-sensitive lipase, and peroxisome proliferator-activated receptor gamma expression in adipose tissue of familial combined hyperlipidemia patients.
Ylitalo K; Nuotio I; Viikari J; Auwerx J; Vidal H; Taskinen MR
Metabolism; 2002 May; 51(5):664-70. PubMed ID: 11979403
[TBL] [Abstract][Full Text] [Related]
2. Reduced hormone-sensitive lipase activity is not a major metabolic defect in Finnish FCHL families.
Ylitalo K; Large V; Pajukanta P; Reynisdottir S; Porkka KV; Vakkilainen J; Nuotio I; Taskinen MR; Arner P
Atherosclerosis; 2000 Dec; 153(2):373-81. PubMed ID: 11164426
[TBL] [Abstract][Full Text] [Related]
3. Adipose tissue lipoprotein lipase and hormone-sensitive lipase. Contrasting findings in familial combined hyperlipidemia and insulin resistance syndrome.
Reynisdottir S; Angelin B; Langin D; Lithell H; Eriksson M; Holm C; Arner P
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2287-92. PubMed ID: 9351402
[TBL] [Abstract][Full Text] [Related]
4. Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia.
Eurlings PM; van der Kallen CJ; Vermeulen VM; de Bruin TW
Mol Genet Metab; 2003 Nov; 80(3):296-301. PubMed ID: 14680975
[TBL] [Abstract][Full Text] [Related]
5. In vivo evidence of defective postprandial and postabsorptive free fatty acid metabolism in familial combined hyperlipidemia.
Meijssen S; Cabezas MC; Twickler TB; Jansen H; Erkelens DW
J Lipid Res; 2000 Jul; 41(7):1096-102. PubMed ID: 10884291
[TBL] [Abstract][Full Text] [Related]
6. In vivo modulation of plasma free fatty acids in patients with familial combined hyperlipidemia using lipid-lowering medication.
Meijssen S; Derksen RJ; Bilecen S; Erkelens DW; Cabezas MC
J Clin Endocrinol Metab; 2002 Apr; 87(4):1576-80. PubMed ID: 11932285
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in postprandial ketone bodies in normolipidemic subjects and in untreated patients with familial combined hyperlipidemia.
Halkes CJ; van Dijk H; Verseyden C; de Jaegere PP; Plokker HW; Meijssen S; Erkelens DW; Cabezas MC
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1875-80. PubMed ID: 12933534
[TBL] [Abstract][Full Text] [Related]
8. Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus.
van der Kallen CJ; Voors-Pette C; Bouwman FG; Keizer HA; Lu JY; van de Hulst RR; Bianchi R; Janssen MJ; Keulen ET; Boeckx WD; Rotter JI; de Bruin TW
Atherosclerosis; 2002 Oct; 164(2):337-46. PubMed ID: 12204806
[TBL] [Abstract][Full Text] [Related]
9. Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia.
Meijssen S; van Dijk H; Verseyden C; Erkelens DW; Cabezas MC
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):811-6. PubMed ID: 12006395
[TBL] [Abstract][Full Text] [Related]
10. Relationship between peroxisome proliferator-activated receptor gamma and retinoic acid receptor alpha gene expression in obese human adipose tissue.
Redonnet A; Bonilla S; Noël-Suberville C; Pallet V; Dabadie H; Gin H; Higueret P
Int J Obes Relat Metab Disord; 2002 Jul; 26(7):920-7. PubMed ID: 12080444
[TBL] [Abstract][Full Text] [Related]
11. Decreased fatty acid esterification compensates for the reduced lipolytic activity in hormone-sensitive lipase-deficient white adipose tissue.
Zimmermann R; Haemmerle G; Wagner EM; Strauss JG; Kratky D; Zechner R
J Lipid Res; 2003 Nov; 44(11):2089-99. PubMed ID: 12923228
[TBL] [Abstract][Full Text] [Related]
12. Serum C3 but not plasma acylation-stimulating protein is elevated in Finnish patients with familial combined hyperlipidemia.
Ylitalo K; Pajukanta P; Meri S; Cantor RM; Mero-Matikainen N; Vakkilainen J; Nuotio I; Taskinen MR
Arterioscler Thromb Vasc Biol; 2001 May; 21(5):838-43. PubMed ID: 11348883
[TBL] [Abstract][Full Text] [Related]
13. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
Reynisdottir S; Eriksson M; Angelin B; Arner P
J Clin Invest; 1995 May; 95(5):2161-9. PubMed ID: 7738184
[TBL] [Abstract][Full Text] [Related]
14. Age-related differences in messenger ribonucleic acid expression of key proteins involved in adipose cell differentiation and metabolism.
Imbeault P; Vidal H; Tremblay A; Vega N; Nadeau A; Després JP; Mauriège P
J Clin Endocrinol Metab; 2001 Feb; 86(2):828-33. PubMed ID: 11158053
[TBL] [Abstract][Full Text] [Related]
15. Fat-reducing effects of dehydroepiandrosterone involve upregulation of ATGL and HSL expression, and stimulation of lipolysis in adipose tissue.
Karbowska J; Kochan Z
Steroids; 2012 Nov; 77(13):1359-65. PubMed ID: 22951290
[TBL] [Abstract][Full Text] [Related]
16. The Pro12A1a substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia.
Pihlajamäki J; Miettinen R; Valve R; Karjalainen L; Mykkänen L; Kuusisto J; Deeb S; Auwerx J; Laakso M
Atherosclerosis; 2000 Aug; 151(2):567-74. PubMed ID: 10924736
[TBL] [Abstract][Full Text] [Related]
17. Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy.
Catalano PM; Nizielski SE; Shao J; Preston L; Qiao L; Friedman JE
Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E522-33. PubMed ID: 11832353
[TBL] [Abstract][Full Text] [Related]
18. Impaired insulin-stimulated glucose oxidation and free fatty acid suppression in patients with familial combined hyperlipidemia: a precursor defect for dyslipidemia?
Karjalainen L; Pihlajamäki J; Karhapää P; Laakso M
Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1548-53. PubMed ID: 9763525
[TBL] [Abstract][Full Text] [Related]
19. Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia.
Verseyden C; Meijssen S; van Dijk H; Jansen H; Castro Cabezas M
J Lipid Res; 2003 Nov; 44(11):2100-8. PubMed ID: 12923226
[TBL] [Abstract][Full Text] [Related]
20. Leptin, peroxisome proliferator-activated receptor-gamma, and CCAAT/enhancer binding protein-alpha mRNA expression in adipose tissue of humans and their relation to cardiovascular risk factors.
Krempler F; Breban D; Oberkofler H; Esterbauer H; Hell E; Paulweber B; Patsch W
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):443-9. PubMed ID: 10669642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
